"Cardiology Associates of North Mississippi can trace its roots back over twenty years to the internists that formed Internal Medicine Associates of Tupelo in 1976. CANM doctors were also responsible for opening north Mississippi’s first Cardiac Catheterization Lab in February 1981, as well as many other accomplishments along the way. Of late, CANM has expanded both geographically and in its breadth of services. As it stands today, CANM boasts 20 full time cardiology specialists, who together cover the continuum of modern cardiac care."

During the past decade, Cardiology Associates Research, LLC conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 20 clinical trials were completed, i.e. on average, 64.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 12 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiology Associates Research, LLC" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "AtriCure, Inc." with 3 trials sponsored, "Biotronik, Inc." with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Associates Research, LLC" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator and "Biotronik, Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Associates Research, LLC" are "Heart Failure" (9 trials), "Atrial Fibrillation" (5 trials), "Coronary Artery Disease" (5 trials), "Cardiovascular Diseases" (4 trials) and "Hypertension" (4 trials). Many other conditions were trialed in "Cardiology Associates Research, LLC" in a lesser frequency.

Most popular intervention types in "Cardiology Associates Research, LLC" are "Device" (25 trials), "Drug" (17 trials), "Other" (6 trials), "Procedure" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Apixaban" (2 trials), "Sham Procedure" (2 trials), "Symplicity Spyral™ multi-electrode renal denervation system" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Associates Research, LLC" are 45 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiology Associates Research, LLC". undefined are not yet recruiting, 7 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Cardiology Associates Research, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Associates Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 17 trials that are defined as “Not Applicable".